Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 multiple-dose, parallel-group study evaluating AMA0076 in patients with primary open-angle glaucoma or ocular hypertension has com…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma [Phase 1]
Phase 1 trial update on INS115644 ophthalmic solution in subjects with ocular hypertension or open-angle glaucoma; the study status is COMPL…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 trial comparing T2345 to an active comparator in newly diagnosed open-angle glaucoma or ocular hypertension, with pharmacokinetics…
-
CLINICAL_TRIALS research · 2015-01-06Clinical Trial Update: Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines
A clinical trial update assessing the efficacy of selective laser trabeculoplasty in patients with glaucoma or ocular hypertension who are a…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients
An update on a clinical trial evaluating the efficacy of selective laser trabeculoplasty in pseudophakic patients with glaucoma or ocular hy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2014-12-19FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC.)
FDA approved a supplemental application for betaxolol hydrochloride from KVK-Tech, Inc., resulting in changes to the drug's labeling.
-
FDA approval · 2014-12-19FDA Approved: BETAXOLOL — Supplemental Application (Epic Pharma LLC)
The FDA approved a supplemental application (ANDA075541) for Betaxolol from Epic Pharma LLC, marking an approved change under the ANDA proce…
-
CLINICAL_TRIALS research · 2014-12-17Clinical Trial Update: A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension [Phase 1]
Phase 1 clinical trial update for the VISION5 product in ocular hypertension and primary open-angle glaucoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Neurovascular Coupling in Eyes of Glaucoma Patients
A completed clinical trial from University Hospital Basel investigating neurovascular coupling in the eyes of glaucoma and ocular hypertensi…
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH [Phase 3]
A Phase 3 trial comparing latanoprost/brinzolamide to latanoprost alone in open-angle glaucoma or ocular hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Safety Study of Latanoprost Slow Release Insert [Phase 1]
Phase 1 safety study of the latanoprost slow-release insert was terminated in participants with primary open-angle glaucoma or ocular hypert…
-
FDA approval · 2014-11-25FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost from Mylan Pharmaceuticals Inc., supporting a generic latanoprost product. This …
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of T2345 in patients with glaucoma or ocular hypertension has completed with result…
-
FDA approval · 2014-11-18FDA Approved: BRIMONIDINE TARTRATE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved Brimonidine tartrate from Florida Pharmaceutical Products, LLC under an Original Application (ANDA), enabling its entry as a ge…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [NA]
A completed clinical trial update evaluating the effects of fixed-combination glaucoma therapies Xalacom (latanoprost/timolol) and Combigan …
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients. [Phase 4]
Phase 4 study evaluating the safety and efficacy of Geltim LP 1 mg/g in ocular hypertensive or glaucomatous patients. Results have been post…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma [Phase 4]
Phase 4 clinical trial update evaluating the effects of preservative-free prostaglandin eye drops on signs and symptoms in patients with gla…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost [Phase 2]
A Phase 2 study comparing ALZ-1101 to Latanoprost in patients whose intraocular pressure remains inadequately controlled by Latanoprost has …
-
FDA approval · 2014-09-29FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lumigan (bimatoprost) submitted by Allergan, Inc.
-
FDA approval · 2014-09-25FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Brimonidine Tartrate filed by Sandoz Inc. The document does not specify the exact scope of t…
-
FDA approval · 2014-09-25FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for betaxolol hydrochloride (Sandoz Inc). The action involves updating the product labeling.
-
FDA approval · 2014-09-25FDA Approved: TIMOLOL GFS — Supplemental Application (Sandoz Inc)
FDA approved the supplemental application for TIMOLOL GFS (timolol maleate) from Sandoz Inc.
-
FDA approval · 2014-09-19FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for LUMIGAN (bimatoprost).
-
FDA approval · 2014-09-11FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved an original ANDA for dorzolamide hydrochloride ophthalmic solution (generic) from Florida Pharmaceutical Products, LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating a triple combination therapy for open-angle glaucoma or ocular hypertension; safety and efficacy results were poste…